Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent or Chronic ITP”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Post-approval studies (Phase 4)Study completedNCT03119974
What this trial is testing

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

Who this might be right for
Persistent or Chronic ITP
Assistance Publique - Hôpitaux de Paris 48
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Not applicableLooking for participantsNCT06568913
What this trial is testing

The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

Who this might be right for
Persistent or Chronic ITP Not Respnding to Steroids
Sohag University 100
Post-approval studies (Phase 4)UnknownNCT05718856
What this trial is testing

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 166
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Testing effectiveness (Phase 2)UnknownNCT05232149
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Beijing InnoCare Pharma Tech Co., Ltd. 30
Large-scale testing (Phase 3)Ended earlyNCT04200456
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 33
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Large-scale testing (Phase 3)UnknownNCT03177629
What this trial is testing

H. Pylori Eradication for Moderate ITP

Who this might be right for
Immune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia
Seoul National University Hospital 54
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Early research (Phase 1)Ended earlyNCT03275740
What this trial is testing

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Who this might be right for
HealthyPrimary Immune ThrombocytopeniaPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Pfizer 58
Large-scale testing (Phase 3)Active Not RecruitingNCT04562766
What this trial is testing

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 232
Large-scale testing (Phase 3)Ended earlyNCT04596995
What this trial is testing

Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 43
Testing effectiveness (Phase 2)Ended earlyNCT01054443
What this trial is testing

Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Shionogi 20
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shionogi 19